Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508.

Clark JI, Moon J, Hutchins LF, Sosman JA, Kast WM, Da Silva DM, Liu PY, Thompson JA, Flaherty LE, Sondak VK
Cancer. 2010 116 (2): 424-31

PMID: 19918923 · PMCID: PMC2811758 · DOI:10.1002/cncr.24739

MeSH Terms (14)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Dacarbazine Female Humans Male Melanoma Middle Aged Neoplasm Metastasis Skin Neoplasms Temozolomide Thalidomide

Connections (1)

This publication is referenced by other Labnodes entities: